Diarrhoea associated with heat-stable enterotoxin-producing strains of Escherichia coli.

Heat-stable enterotoxin of Escherichia coli: in vitro effects on guanylate cyclase activity, cyclic GMP concentration, and ion transport in small intestine. Proc Natl Acad Sci U S A (1978) 6.01

Suckling mouse model for detection of heat-stable Escherichia coli enterotoxin: characteristics of the model. Infect Immun (1976) 5.86

Biological evaluation of a methanol-soluble, heat-stable Escherichia coli enterotoxin in infant mice, pigs, rabbits, and calves. Infect Immun (1978) 4.45

Production of enterotoxin by Yersinia enterocolitica. Infect Immun (1978) 3.94

Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34

Patterns of loss of enterotoxigenicity by Escherichia coli isolated from adults with diarrhea: suggestive evidence for an interrelationship with serotype. Infect Immun (1977) 3.04

Purification and chemical characterization of the heat-labile enterotoxin produced by enterotoxigenic Escherichia coli. Infect Immun (1979) 2.80

Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin. Infect Immun (1977) 2.49

Immunity to enterotoxigenic Escherichia coli. Infect Immun (1979) 2.30

Limitations of the infant mouse test for Escherichia coli heat stable enterotoxin. Can J Comp Med (1979) 2.18

Antibodies to heat-labile Escherichia coli enterotoxin in Apaches in Whiteriver, Arizona. Infect Immun (1975) 1.75

Plasmid-mediated properties of a heat-stable enterotoxin-producing Escherichia coli associated with infantile diarrhea. Infect Immun (1976) 1.67

Immunological interrelationships between cholera toxin and the heat-labile and heat-stable enterotoxins of coliform bacteria. Infect Immun (1977) 1.67

Characterization of a partially purified methanol-soluble heat-stable Escherichia coli enterotoxin in infant mice. Infect Immun (1978) 1.63

Mechanism of action of Yersinia enterocolitica enterotoxin. Infect Immun (1979) 1.61

Production of heat-stable enterotoxin by the O128 serogroup of Escherichia coli. Infect Immun (1979) 1.48

Enzyme-linked immunosorbent assay for Escherichia coli heat-stable enterotoxin. J Clin Microbiol (1984) 1.47

Production of heat-labile or heat-stable enterotoxins by strains of Escherichia coli belonging to serogroups O44, O114, and O128. Infect Immun (1981) 1.35

Assay of Escherichia coli enterotoxins by in vivo perfusion in the rat jejunum. Infect Immun (1976) 1.28

Enterotoxigenic Escherichia coli in a population of infants with diarrhea in Chile. J Clin Microbiol (1985) 1.19

Protective effect of active immunization with purified Escherichia coli heat-labile enterotoxin in rats. Infect Immun (1979) 1.17

Protection in rats immunized with Escherichia coli heat-stable enterotoxin. Infect Immun (1981) 1.13

Enterotoxigenic Escherichia coli in central Canada. J Clin Microbiol (1980) 1.11

Partial purification and properties of Enterobacter cloacae heat-stable enterotoxin. Infect Immun (1976) 1.10

Inhibition of the secretory activity of Escherichia coli heat-stable enterotoxin by indomethacin. Infect Immun (1978) 1.06

Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli. Antimicrob Agents Chemother (1981) 1.03

Distribution of heat-stable enterotoxin/guanylin receptors in the intestinal tract of man and other mammals. J Anat (1994) 1.02

Effect of chlorpromazine on the secretory activity of Escherichia coli heat-stable enterotoxin. Infect Immun (1979) 0.98

Pooling method for screening large numbers of Escherichia coli for production of heat-stable enterotoxin, and its application in field studies. J Clin Microbiol (1979) 0.93

Enterotoxin production, presence of colonization factor antigen I, and adherence to HeLa cells by Escherichia coli O128 strains belonging to different O subgroups. Infect Immun (1985) 0.91

Novel antigens for enterotoxigenic Escherichia coli vaccines. Expert Rev Vaccines (2014) 0.90

Intestinal receptor for heat-stable enterotoxin of Escherichia coli is tightly coupled to a novel form of particulate guanylate cyclase. Infect Immun (1986) 0.88

Activation of particulate guanylate cyclase by Escherichia coli heat-stable enterotoxin is regulated by adenine nucleotides. Infect Immun (1991) 0.83

Comparison of three assay systems for detection of enterotoxigenic Escherichia coli heat-stable enterotoxin. J Clin Microbiol (1990) 0.79

Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med (1983) 25.72

Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture. Infect Immun (1975) 13.58

Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. N Engl J Med (1979) 10.57

Laboratory investigation of hemorrhagic colitis outbreaks associated with a rare Escherichia coli serotype. J Clin Microbiol (1983) 10.23

Human diarrheal disease caused by enterotoxigenic Escherichia coli. Annu Rev Microbiol (1975) 9.01

Laboratory investigation of a multistate food-borne outbreak of Escherichia coli O157:H7 by using pulsed-field gel electrophoresis and phage typing. J Clin Microbiol (1994) 8.37

Plasmid-mediated tissue invasiveness in Yersinia enterocolitica. Nature (1980) 8.15

The magnitude of the global problem of acute diarrhoeal disease: a review of active surveillance data. Bull World Health Organ (1982) 7.88

Isolation of the Legionnaires' disease bacterium from environmental samples. Ann Intern Med (1979) 7.69

Human reovirus-like agent as the major pathogen associated with "winter" gastroenteritis in hospitalized infants and young children. N Engl J Med (1976) 7.57

Enterotoxigenic Escherichia coli isolated from patients with severe cholera-like disease. J Infect Dis (1971) 7.10

Isolation of Legionella spp. from environmental water samples by low-pH treatment and use of a selective medium. J Clin Microbiol (1981) 6.88

Travelers' diarrhea in Mexico. A prospective study of physicians and family members attending a congress. N Engl J Med (1976) 6.52

Acute undifferentiated human diarrhea in the tropics. I. Alterations in intestinal micrflora. J Clin Invest (1971) 6.23

Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum. Ann Intern Med (1988) 5.92

An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA (1993) 5.87

Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet (1993) 5.48

Immunologic cross-reactions of enterotoxins from Escherichia coli and Vibrio cholerae. J Infect Dis (1973) 5.46

Enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin. J Clin Microbiol (1977) 5.17

Special Escherichia coli serotypes among enterotoxigenic strains from diarrhoea in adults and children. Med Microbiol Immunol (1976) 4.95

Endemic cholera in rural Bangladesh, 1966-1980. Am J Epidemiol (1982) 4.93

Structural interventions in public health. AIDS (2000) 4.86

A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience. JAMA (1994) 4.85

Antistreptokinase titres after intravenous streptokinase. Lancet (1990) 4.77

Seasonal affective disorder. A description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry (1984) 4.72

Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up. Lancet (1990) 4.62

Campylobacter enteritis in the United States. A multicenter study. Ann Intern Med (1983) 4.60

Practice guidelines for the management of infectious diarrhea. Clin Infect Dis (2001) 4.49

Isolation of Escherichia coli O157:H7 from dairy cattle associated with two cases of haemolytic uraemic syndrome. Lancet (1986) 4.44

Toward a population genetic analysis of Salmonella: genetic diversity and relationships among strains of serotypes S. choleraesuis, S. derby, S. dublin, S. enteritidis, S. heidelberg, S. infantis, S. newport, and S. typhimurium. Proc Natl Acad Sci U S A (1988) 4.43

Legionella gormanii sp. nov. J Clin Microbiol (1980) 4.12

Preparation and testing of polyvalent conjugates for fluorescent-antibody detection of salmonellae. Appl Microbiol (1971) 4.06

Experimental canine cholera. I. Development of the model. J Infect Dis (1969) 4.02

A two-year study of bacterial, viral, and parasitic agents associated with diarrhea in rural Bangladesh. J Infect Dis (1980) 3.96

Sporadic cases of hemorrhagic colitis associated with Escherichia coli O157:H7. Ann Intern Med (1984) 3.88

A waterborne outbreak in Missouri of Escherichia coli O157:H7 associated with bloody diarrhea and death. Ann Intern Med (1992) 3.87

Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol (1981) 3.75

Attachment of Vibrio cholerae serogroup O1 to zooplankton and phytoplankton of Bangladesh waters. Appl Environ Microbiol (1990) 3.73

Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera. J Clin Invest (1968) 3.72

Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect Immun (1981) 3.69

Cytotoxic enterotoxin produced by Aeromonas hydrophila: relationship of toxigenic isolates to diarrheal disease. Infect Immun (1979) 3.65

Escherichia coli O157:H7 diarrhea in a nursing home: clinical, epidemiological, and pathological findings. J Infect Dis (1986) 3.62

Production of Shiga-like toxin by Escherichia coli. J Infect Dis (1986) 3.53

Enterotoxigenic Escherichia coli isolated from food. J Infect Dis (1977) 3.52

Cholera control. Lancet (1994) 3.38

Enterotoxigenic Escherichia coli and Reovirus-like agent in rural Bangladesh. Lancet (1976) 3.38

Laboratory investigation of diarrhea in travelers to Mexico: evaluation of methods for detecting enterotoxigenic Echerichia coli. J Clin Microbiol (1976) 3.34

Microtiter ganglioside enzyme-linked immunosorbent assay for vibrio and Escherichia coli heat-labile enterotoxins and antitoxin. J Clin Microbiol (1980) 3.30

The molecular epidemiology of cholera in Latin America. J Infect Dis (1993) 3.26

Oral rehydration therapy of infantile diarrhea: a controlled study of well-nourished children hospitalized in the United States and Panama. N Engl J Med (1982) 3.24

Detection of Vibrio cholerae O1 in the aquatic environment by fluorescent-monoclonal antibody and culture methods. Appl Environ Microbiol (1990) 3.21

The United States National Prospective Hemolytic Uremic Syndrome Study: microbiologic, serologic, clinical, and epidemiologic findings. J Infect Dis (2001) 3.14

Case-control study of enteropathogens associated with childhood diarrhea in Dhaka, Bangladesh. J Clin Microbiol (1999) 3.11

Intestinal fluid and electrolyte transport in human cholera. J Clin Invest (1970) 3.09

Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine. J Infect Dis (1984) 3.07

A controlled trial of bismuth subsalicylate in infants with acute watery diarrheal disease. N Engl J Med (1993) 3.07

Giardiasis in day-care centers: evidence of person-to-person transmission. Pediatrics (1977) 3.06

Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae. J Bacteriol (1969) 3.01

Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center. J Pediatr (1986) 2.98

Antitoxin responses to infections with enterotoxigenic Escherichia coli. J Infect Dis (1974) 2.88

Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya. N Engl J Med (1978) 2.86

Field trial of oral cholera vaccines in Bangladesh. Lancet (1986) 2.85

Scombroid fish poisoning. Outbreak traced to commercially canned tuna fish. JAMA (1974) 2.84

Epidemic diarrhea at Crater Lake from enterotoxigenic Escherichia coli. A large waterborne outbreak. Ann Intern Med (1977) 2.80

Enterotoxigenic Escherichia-coli-associated diarrheal disease in Apache children. N Engl J Med (1975) 2.74

Microtiter solid-phase radioimmunoassay for detection of Escherichia coli heat-labile enterotoxin. Infect Immun (1977) 2.72

Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism. JAMA (1977) 2.71

Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol (2000) 2.69

Vibriocidal and agglutinating antibody patterns in cholera patients. J Infect Dis (1966) 2.67

Incidence and severity of rotavirus and Escherichia coli diarrhoea in rural Bangladesh. Implications for vaccine development. Lancet (1981) 2.65

El Tor cholera with severe disease: a new threat to Asia and beyond. Epidemiol Infect (2009) 2.60

Isolation of enterotoxigenic Bacteroides fragilis from humans with diarrhea. J Clin Microbiol (1987) 2.58

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J Infect Dis (1988) 2.57

Methodological issues in diarrhoeal diseases epidemiology: definition of diarrhoeal episodes. Int J Epidemiol (1991) 2.56

Emergence of a new Vibrio parahaemolyticus serotype in raw oysters: A prevention quandary. JAMA (2000) 2.48

Cholera on Guam, 1974: epidemiologic findings and isolation of non-toxinogenic strains. Am J Epidemiol (1977) 2.46

Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis. J Clin Microbiol (1987) 2.44

Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology. Infect Immun (1992) 2.41